Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
2(14%)
Results Posted
58%(7 trials)

Phase Distribution

Ph phase_1
3
21%
Ph phase_2
1
7%
Ph phase_4
5
36%
Ph not_applicable
1
7%
Ph phase_3
3
21%
Ph early_phase_1
1
7%

Phase Distribution

4

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 1Safety & dosage
3(21.4%)
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
3(21.4%)
Phase 4Post-market surveillance
5(35.7%)
N/ANon-phased studies
1(7.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(12)

Detailed Status

Completed12
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.1%)
Phase 13 (21.4%)
Phase 21 (7.1%)
Phase 33 (21.4%)
Phase 45 (35.7%)
N/A1 (7.1%)

Trials by Status

recruiting214%
completed1286%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT06582888Early Phase 1

Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder

Recruiting
NCT05703672Phase 3

Switching to E-cigarettes in Smokers Not Interested in Quitting

Recruiting
NCT05541497Phase 2

Varenicline for Treatment of E-cigarette Dependence

Completed
NCT03235505Phase 4

Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers

Completed
NCT03897439Phase 3

Individualizing Pharmacotherapy for African American Smokers

Completed
NCT00701896Not Applicable

Smoking Cessation Using Motivational Therapy and Varenicline

Completed
NCT01574703Phase 4

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

Completed
NCT01456936Phase 4

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders

Completed
NCT00717093Phase 4

Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

Completed
NCT00371813Phase 3

An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

Completed
NCT01370356Phase 4

A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction

Completed
NCT00527150Phase 1

Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers

Completed
NCT00661765Phase 1

A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.

Completed
NCT00452894Phase 1

Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14